A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008
Condition:   Erosive Esophagitis Interventions:   Drug: H008;   Drug: H008 placebo;   Drug: Lansoprazole Sponsor:   Jiangsu Carephar Pharmaceutical Co., Ltd. Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 20, 2021 Category: Research Source Type: clinical trials

Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer
Condition:   Duodenal Ulcer Interventions:   Drug: LXI-15028 50mg group;   Drug: Lansoprazole 30mg group Sponsor:   Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2021 Category: Research Source Type: clinical trials